BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25246291)

  • 1. Risk factors in diabetic nephropathy progression at present.
    Lizicarova D; Krahulec B; Hirnerova E; Gaspar L; Celecova Z
    Bratisl Lek Listy; 2014; 115(8):517-21. PubMed ID: 25246291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group.
    Schwartz MM; Lewis EJ; Leonard-Martin T; Lewis JB; Batlle D
    Nephrol Dial Transplant; 1998 Oct; 13(10):2547-52. PubMed ID: 9794557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review.
    Wal P; Tyagi S; Pal RS; Yadav A; Jaiswal R
    Curr Diabetes Rev; 2023; 19(5):e260422204036. PubMed ID: 35993472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.
    White KE; Marshall SM; Bilous RW
    Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic classification of diabetic nephropathy.
    Tervaert TW; Mooyaart AL; Amann K; Cohen AH; Cook HT; Drachenberg CB; Ferrario F; Fogo AB; Haas M; de Heer E; Joh K; Noël LH; Radhakrishnan J; Seshan SV; Bajema IM; Bruijn JA;
    J Am Soc Nephrol; 2010 Apr; 21(4):556-63. PubMed ID: 20167701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of lipids in the progression of diabetic nephropathy.
    Krämer-Guth A; Quaschning T; Greiber S; Wanner C
    Clin Nephrol; 1996 Oct; 46(4):262-5. PubMed ID: 8905213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature.
    Navaneethan SD; Singh S; Choudhry W
    J Nephrol; 2005; 18(5):613-5. PubMed ID: 16299690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury and Progression of Diabetic Kidney Disease.
    Yu SM; Bonventre JV
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):166-180. PubMed ID: 29580581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, metabolic syndrome and diabetic nephropathy.
    Maric C; Hall JE
    Contrib Nephrol; 2011; 170():28-35. PubMed ID: 21659755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I; Covarsí A; Novillo R; Gómez-Martino JR; Ferrando L
    Nefrologia; 2002; 22(2):162-9. PubMed ID: 12085417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and morphometrical interrelationships in patients with overt nephropathy induced by non-insulin-dependent diabetes mellitus. A light- and electron-microscopy study.
    Matsumae T; Jimi S; Uesugi N; Takebayashi S; Naito S
    Nephron; 1999 Jan; 81(1):41-8. PubMed ID: 9884418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of incipient nephropathy in type 2 diabetes mellitus.
    Lemley KV; Abdullah I; Myers BD; Meyer TW; Blouch K; Smith WE; Bennett PH; Nelson RG
    Kidney Int; 2000 Sep; 58(3):1228-37. PubMed ID: 10972685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.